CYCLERION THERAPEUTICS Trademark

Trademark Overview


On Wednesday, February 22, 2023, a trademark application was filed for CYCLERION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CYCLERION THERAPEUTICS trademark a serial number of 97806500. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 5, 2024. This trademark is owned by Cyclerion Therapeutics, Inc.. The CYCLERION THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, neuropsychiatric diseases, mood disorders, mental diseases, neurodegenerative diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds
cyclerion therapeutics

General Information


Serial Number97806500
Word MarkCYCLERION THERAPEUTICS
Filing DateWednesday, February 22, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, March 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, neuropsychiatric diseases, mood disorders, mental diseases, neurodegenerative diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCyclerion Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameCyclerion Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 27, 2023NON-FINAL ACTION E-MAILED
Monday, November 27, 2023NON-FINAL ACTION WRITTEN
Tuesday, November 21, 2023ASSIGNED TO EXAMINER
Monday, March 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 25, 2023NEW APPLICATION ENTERED